Recursion OS
Drug-discovery platform combining automated cell-biology experiments with machine-learning models over the resulting data.
Find alternatives to Recursion OS
An internal and partnership platform rather than a self-serve product; a 318-URL sitemap carries no pricing page, checked 2026-08-21.
What it does
- Drug discovery
How it compares
-
Drug Design Engine
Both are AI-native drug-discovery platforms — Recursion OS against Isomorphic's Drug Design Engine — named as rivals in Recursion's own 10-K.
Representative examples include Relay Therapeutics, Isomorphic Labs, Schrodinger, and AbCellera.
Regulatory filing · 25 Feb 2026 -
Pharma.AI
Both platforms screen and design drug candidates with AI/ML; Insilico's own HKEX prospectus names Recursion in its Competitive Landscape table.
The table below shows the comparison of the major global AI pharmaceutical companies.
Regulatory filing · 18 Dec 2025
Sources
- Sold within
-
Recursion describes "The Recursion Operating System (OS), Recursion's proprietary AI drug discovery and drug development platform" that feeds its own clinical pipeline. The page offers no plan, price, signup or licence for it.
Open Recursion Pharmaceuticals in the directory
Something wrong here? Send a correction — quote this product id: recursion-os.